Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2025-06-11 Capital/Financing Update
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service/Korea Exchange, specifically detailing a 'Decision on Paid-in Capital Increase' (유상증자결정). It outlines the issuance of new shares, the purpose of the capital raise (operating funds), the third-party allocation method, and the specific details of the entities involved. This falls under the category of capital structure changes and financing activities.
2025-06-11 Korean
주요사항보고서(유형자산양도결정)
Regulatory Filings Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Services Commission and the Korea Exchange. It details a specific corporate action: the decision to dispose of tangible assets (real estate) to improve financial structure. This type of regulatory filing regarding asset disposal does not fit into specific categories like earnings releases or annual reports, and it is not a mere announcement of a report (RPA). Therefore, it falls under the 'Regulatory Filings' category as a general corporate disclosure.
2025-06-11 Korean
주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for SCM Lifescience, detailing the date, location, and agenda items (election of directors). This type of document is a standard proxy solicitation or meeting notice provided to shareholders to inform them of upcoming voting procedures. Given the specific category list, 'PSI' (Proxy Solicitation & Information Statement) is the most accurate classification for a notice of a shareholder meeting and its agenda.
2025-05-28 Korean
주주명부폐쇄기간또는기준일설정 (임시주주총회)
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for an upcoming Extraordinary General Meeting (EGM). It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal notice of the record date for shareholder rights. Given it is a regulatory disclosure regarding meeting logistics, it falls under the general regulatory filing category.
2025-05-28 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (임시주주총회결과) held on May 14, 2025. It details the voting outcomes for specific agenda items, including the amendment of articles of incorporation and the appointment of directors. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2025-05-14 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment, dismissal, or resignation of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of Board/Management Information, as it details changes to the company's board composition.
2025-05-14 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.